SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271–289.
   PubMed Web of Science ®Google Scholar
• Goodman A. HPV testing as a screen for cervical cancer. BMJ. 2015;350:h2372.
   PubMed Web of Science ®Google Scholar
• Peirson L, Fitzpatrick-Lewis D, Ciliska D, et al. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013;2:35.
   PubMedGoogle Scholar
• Zhang X, Zhang L, Tian C, et al. Genetic variants and risk of cervical cancer: epidemiological evidence, meta-analysis and research review. BJOG: Int J Obstet Gy. 2014;121:664–674.
   PubMed Web of Science ®Google Scholar
• du Toit GC, Kidd M. Prospective quality of life study of South African women undergoing treatment for advanced-stage cervical cancer. Clin Ther. 2015;37:2324–2331.
   PubMed Web of Science ®Google Scholar
• Pircher A, Gebetsberger J, Polacek N. Ribosome-associated ncRNAs: an emerging class of translation regulators. RNA Biol. 2014;11:1335–1339.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Kim J, Gorospe M. Long noncoding RNA turnover. Biochimie. 2015;117:15–21.
   PubMed Web of Science ®Google Scholar
• Yang L, Froberg JE, Lee JT. Long noncoding RNAs: fresh perspectives into the RNA world. Trends Biochem Sci. 2014;39:35–43.
   PubMed Web of Science ®Google Scholar
• Booton R, Lindsay MA. Emerging role of MicroRNAs and long noncoding RNAs in respiratory disease. Chest. 2014;146:193–204.
   PubMed Web of Science ®Google Scholar
• Martens-Uzunova ES, Bottcher R, Croce CM, et al. Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol. 2014;65:1140–1151.
   PubMed Web of Science ®Google Scholar
• Luo D, Deng B, Weng M, et al. A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma. Artif Cells Nanomed Biotechnol. 2018;46:1207–1214.
   PubMed Web of Science ®Google Scholar
• Liu C, Tian X, Zhang J, et al. Long non-coding RNA DLEU1 promotes proliferation and invasion by interacting with miR-381 and enhancing HOXA13 expression in cervical cancer. Front Genet. 2018;9:629.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim LK, Lee SH, et al. Expression levels of the long noncoding RNA steroid receptor activator promote cell proliferation and invasion and predict patient prognosis in human cervical cancer. Oncol Lett. 2018;16:5410–5418.
   PubMed Web of Science ®Google Scholar
• Sharma S, Munger K. Expression of the cervical carcinoma expressed PCNA regulatory (CCEPR) long noncoding RNA is driven by the human papillomavirus E6 protein and modulates cell proliferation independent of PCNA. Virology. 2018;518:8–13.
   PubMed Web of Science ®Google Scholar
• Xiao H, Bao L, Xiao W, et al. Long non-coding RNA Lucat1 is a poor prognostic factor and demonstrates malignant biological behavior in clear cell renal cell carcinoma. Oncotarget. 2017;8:113622–113634.
   PubMedGoogle Scholar
• Thai P, Statt S, Chen CH, et al. Characterization of a novel long noncoding RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer cell lines. Am J Respir Cell Mol Biol. 2013;49:204–211.
   PubMed Web of Science ®Google Scholar
• Han Z, Shi L. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis. Biochem Biophys Res Commun. 2018;495:947–953.
   PubMed Web of Science ®Google Scholar
• Haque SU, Niu L, Kuhnell D, et al. Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma. Head Neck. 2018;40:1555–1564.
   PubMed Web of Science ®Google Scholar
• Wang LN, Zhu XQ, Song XS, et al. Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p. J Cell Biochem. 2018;119:7599–7609.
   PubMed Web of Science ®Google Scholar
• Bikhof Torbati M, Ebrahimian M, Yousefi M, et al. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line. Artif Cells Nanomed Biotechnol. 2017;45:568–573.
   PubMed Web of Science ®Google Scholar
• Dasari S, Wudayagiri R, Valluru L. Cervical cancer: biomarkers for diagnosis and treatment. Clin Chim Acta. 2015;445:7–11.
   PubMed Web of Science ®Google Scholar
• Somashekhar SP, Ashwin KR. Management of early stage cervical cancer. Rev Recent Clin Trials. 2015;10:302–308.
   PubMed Web of Science ®Google Scholar
• Cong J, Liu R, Wang X, et al. MiR-634 decreases cell proliferation and induces apoptosis by targeting mTOR signaling pathway in cervical cancer cells. Artif Cells Nanomed Biotechnol. 2016;44:1694–1701.
   PubMed Web of Science ®Google Scholar
• Cheng WS, Tao H, Hu EP, et al. Both genes and lncRNAs can be used as biomarkers of prostate cancer by using high throughput sequencing data. Eur Rev Med Pharmacol Sci. 2014;18:3504–3510.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Wang J, Wang Y, et al. TF2LncRNA: identifying common transcription factors for a list of lncRNA genes from ChIP-Seq data. Biomed Res Int. 2014;2014:1.
   Web of Science ®Google Scholar
• Jiang H, Huang G, Zhao N, et al. Long non-coding RNA TPT1-AS1 promotes cell growth and metastasis in cervical cancer via acting AS a sponge for miR-324-5p. J Exp Clin Cancer Res. 2018;37:169.
   PubMed Web of Science ®Google Scholar
• Liu G, Ye Z, Zhao X, et al. SP1-induced up-regulation of lncRNA SNHG14 as a ceRNA promotes migration and invasion of clear cell renal cell carcinoma by regulating N-WASP. Am J Cancer Res. 2017;7:2515–2525.
   PubMed Web of Science ®Google Scholar
• Wang ZQ, Cai Q, Hu L, et al. Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer. Cell Death Dis. 2017;8:e2839.
   PubMed Web of Science ®Google Scholar
• Yoon JH, You BH, Park CH, et al. The long noncoding RNA LUCAT1 promotes tumorigenesis by controlling ubiquitination and stability of DNA methyltransferase 1 in esophageal squamous cell carcinoma. Cancer Lett. 2018;417:47–57. Mar 28
   PubMed Web of Science ®Google Scholar
• Gao YS, Liu XZ, Zhang YG, et al. Knockdown of long noncoding RNA LUCAT1 inhibits cell viability and invasion by regulating miR-375 in glioma. Oncol Res. 2018;26:307–313.
   PubMed Web of Science ®Google Scholar
• Sun Y, Jin SD, Zhu Q, et al. Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression. Oncotarget. 2017;8:28297–28311.
   PubMedGoogle Scholar
• Liu Y, Liu T, Bao X, et al. Increased EZH2 expression is associated with proliferation and progression of cervical cancer and indicates a poor prognosis. Int J Gynecol Pathol. 2014;33:218–224.
   PubMed Web of Science ®Google Scholar
• Danza K, Silvestris N, Simone G, et al. Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance. Cancer Biol Ther. 2016;17:400–406.
   PubMed Web of Science ®Google Scholar
• Azumi J, Tsubota T, Sakabe T, et al. miR-181a induces sorafenib resistance of hepatocellular carcinoma cells through downregulation of RASSF1 expression. Cancer Sci. 2016;107:1256–1262.
   PubMed Web of Science ®Google Scholar
• Luo C, Qiu J. miR-181a inhibits cervical cancer development via downregulating GRP78. Oncol Res. 2017;25:1341–1348.
   PubMed Web of Science ®Google Scholar
• Chen Y, Ke G, Han D, et al. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD. Exp Cell Res. 2014;320:12–20.
   PubMed Web of Science ®Google Scholar